139 related articles for article (PubMed ID: 14762288)
1. Studying the treatment of chronic hepatitis B viral infection in special populations.
Gish RG; Locarnini S
Methods Mol Med; 2004; 96():465-98. PubMed ID: 14762288
[No Abstract] [Full Text] [Related]
2. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
Fournier C; Zoulim F
Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
[TBL] [Abstract][Full Text] [Related]
3. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
Zoulim F
Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria].
Khelifa F; Thibault V
Pathol Biol (Paris); 2009 Feb; 57(1):107-13. PubMed ID: 18835106
[TBL] [Abstract][Full Text] [Related]
6. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
Isakov VA
Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
[No Abstract] [Full Text] [Related]
7. Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.
Yokosuka O
J Gastroenterol; 2004 Aug; 39(8):813-4. PubMed ID: 15338383
[No Abstract] [Full Text] [Related]
8. [HBV mutations during antiviral therapy in patients with chronic hepatitis B].
Hwang SG
Korean J Hepatol; 2005 Dec; 11(4):311-9. PubMed ID: 16380660
[No Abstract] [Full Text] [Related]
9. [Chronic HBeAg-negative viral gepatitis B: treatment is essential and possible].
Isakov VA
Eksp Klin Gastroenterol; 2007; (5):40-5. PubMed ID: 18389596
[No Abstract] [Full Text] [Related]
10. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
Mauss S; Wedemeyer H
Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
[TBL] [Abstract][Full Text] [Related]
12. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
13. [Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Zoulim F
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S9-11. PubMed ID: 17075488
[No Abstract] [Full Text] [Related]
14. [The genetic variability and clinical significance of hepatitis B virus].
Tang H; Chen EQ
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):161-3. PubMed ID: 19554777
[No Abstract] [Full Text] [Related]
15. Management of hepatitis B patients with antiviral resistance.
Fung SK; Lok AS
Antivir Ther; 2004 Dec; 9(6):1013-26. PubMed ID: 15651760
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy of chronic hepatitis B.
Zoulim F
Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
[TBL] [Abstract][Full Text] [Related]
17. [Chronic hepatitis B].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
[No Abstract] [Full Text] [Related]
18. Chronic hepatitis B: preventing, detecting, and managing viral resistance.
Keeffe EB; Dieterich DT; Pawlotsky JM; Benhamou Y
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):268-74. PubMed ID: 18328434
[TBL] [Abstract][Full Text] [Related]
19. [Clinical consequences of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
Cadranel JF
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S12-6. PubMed ID: 17075489
[No Abstract] [Full Text] [Related]
20. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
